ConductScience.org, home

Gene · 3959

Papers2,653

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Isogenic cortical organoids enable precision targeting of APP variant-specific pathways in Alzheimer's disease.bioRxiv202641757078PubTator, text miningPubMed
Proteomics in IDH-mutated diffuse lower-grade glioma: a scoping review.Neurooncol Adv202641756759PubTator, text miningPubMed
Fetal and Neonatal Immune Response to Congenital Cytomegalovirus (cCMV) Infection: A Systematically Conducted Scoping Review.Viruses202641754585PubTator, text miningPubMed
Moving Toward Objective Diagnosis in Fibromyalgia: Emerging Biomarkers and Digital Phenotyping Tools.Biomedicines202641751339PubTator, text miningPubMed
Different Associations of Plasma Lipopolysaccharide and Lipopolysaccharide-Binding Protein Concentrations with the Deterioration of Energy Metabolism from Healthy Individuals to Patients with Non-Alcoholic Fatty Liver Disease.
Metabolites202641745625PubTator, text miningPubMed
Molecular Characterization of Extracellular Vesicles From Human B Cell Lymphomas: Methodological Comparison to Vesicles From Patient Serum.J Extracell Biol202641737986PubTator, text miningPubMed
Extracellular vesicles and their role in Lupus Nephritis: A scoping review.J Transl Autoimmun202641732236PubTator, text miningPubMed
"Synthetic gp90 peptide ELISA for equine infectious anemia virus: Improved sensitivity and risk factor insights".Prev Vet Med202641719807PubTator, text miningPubMed
Overcoming structural complexity in Galectin-3BP through an integrative computational antibody design workflow.Comput Biol Med202641690254PubTator, text miningPubMed
Comprehensive prognostic and immune infiltration assessment of LGALS3BP in pan-cancer patients.Discov Oncol202641686380PubTator, text miningPubMed
The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive α-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma.
Surg Today202641661322PubTator, text miningPubMed
The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension.Hepatol Res202641644308PubTator, text miningPubMed
Distinct Proteomic and Glycosylation Signatures Differentiate A549 Tumor and BEAS-2B Nontumor Cell Line-Derived Small Extracellular Vesicles.Mol Cell Proteomics202641644049PubTator, text miningPubMed
Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers.World J Hepatol202641640963PubTator, text miningPubMed
Novel perspectives on extracellular vesicles in autoimmune diseases: immunogenicity, inflammation, and immune surveillance.J Clin Invest202641623176PubTator, text miningPubMed
Blood DNA methylation-predicted plasma protein levels and colorectal cancer survival.Clin Epigenetics202641622289PubTator, text miningPubMed
Development of an Indirect ELISA for REV gp90 Antibody Detection Using the gp90 Protein Expressed in Suspended Cells.Viruses202641600885PubTator, text miningPubMed
Correction for Choi et al., Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis.Proc Natl Acad Sci U S A202641591914PubTator, text miningPubMed
Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cure.Sci Rep202641554947PubTator, text miningPubMed
Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan.World J Gastroenterol202641551835PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3959/papers?page=3